728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads

Pre-Market Technical Scan on Biotech Equities — Pluristem Therapeutics, Ritter Pharma, Ignyta, and Tenax Therapeutics

THIS POST WAS ORIGINALLY PUBLISHED ON THIS SITE Click Here To Read Entire Article

NEW YORK, Nov. 29, 2017 /PRNewswire/ — In keeping with the commitment to dynamically provide members with timely information WallStEquities.com has issued free tailored Stock Review on PSTI, RTTR, RXDX, and TENX which is a click away at www.wallstequities.com/registration. On Tuesday, November 28, 2017, US markets saw broad based gains with all sectors finishing the trading sessions in green. Major US indices were also bullish at the close of yesterday’s session. The NASDAQ Composite ended the day at 6,912.36, up 0.49%; the Dow Jones Industrial Average edged 1.09% higher, to finish at 23,836.71; and the S&P 500 closed at 2,627.04, up 0.98%. This Wednesday morning, WallStEquities.com looks at the performance of these four Biotechnology stocks: Pluristem Therapeutics Inc. (NASDAQ: PSTI), Ritter Pharmaceuticals Inc. (NASDAQ: RTTR), Ignyta Inc. (NASDAQ: RXDX), and Tenax Therapeutics Inc. (NASDAQ: TENX). Get your free stock reports on these stocks by registering now on Wall St. Equities at: www.wallstequities.com/registration

Pluristem Therapeutics
On Tuesday, shares in Haifa, Israel-based Pluristem Therapeutics Inc. recorded a trading volume of 219,314 shares. The stock ended the session 3.80% lower at $1.52. The Company’s shares have gained 27.73% over the previous three months. The stock is trading above its 200-day moving average by 12.30%. Moreover, shares of Pluristem Therapeutics, which together with its subsidiary, Pluristem Ltd., operates as a bio-therapeutics company in Israel, have a Relative Strength Index (RSI) of 47.53. Get started with a complimentary subscription and access to the free report on PSTI at: www.wallstequities.com/registration/?symbol=PSTI

Ritter Pharmaceuticals
Los Angeles, California headquartered Ritter Pharmaceuticals Inc.’s stock closed the day 5.13% lower at $0.33 with a total trading volume of 548,105 shares. The stock is trading below its 50-day moving average by 13.85%. Additionally, shares of Ritter Pharma, which develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, have an RSI of 44.00. Free research on RTTR can be accessed at: www.wallstequities.com/registration/?symbol=RTTR

Ignyta
Shares in San Diego, California headquartered Ignyta Inc. recorded a trading volume of 728,691 shares. The stock ended yesterday’s trading session 2.12% higher at $16.85. The Company’s shares have advanced 68.50% over the previous three months, 155.30% in the past twelve months, and 217.92% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 15.86% and 63.11%, respectively. Furthermore, shares of Ignyta, which engages in discovering, in-licensing or acquiring, developing, and commercializing molecularly targeted therapies for eradicating

About The Author

Related posts

Leave a Reply

Your email address will not be published. Required fields are marked *